174 related articles for article (PubMed ID: 8022074)
1. [Detection of antinuclear antibodies and their significance as disease markers].
Yoshida H; Imafuku Y; Morita EO; Nagai T; Kato Y; Motegi S
Rinsho Byori; 1994 May; 42(5):455-9. PubMed ID: 8022074
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
3. [Anti-nuclear antibodies (ANA) in sera of aged subjects, with special reference to two cases with high titers of anti-centromere antibody (ACA)].
Moteki S; Yoshida H; Watanabe N; Sato K; Saito M
Rinsho Byori; 1991 Mar; 39(3):273-7. PubMed ID: 2051602
[TBL] [Abstract][Full Text] [Related]
4. [Immunoserological area--with special reference to the current topics on antinuclear antibodies].
Moteki S; Yoshida H
Rinsho Byori; 1990 Jul; 38(7):765-72. PubMed ID: 2205741
[TBL] [Abstract][Full Text] [Related]
5. [The significance of autoantibodies coexisting with anti-centromere antibodies in sera of patients with primary biliary cirrhosis].
Moteki S; Yoshida H; Nishimaki T; Morito T
Rinsho Byori; 1990 Aug; 38(8):888-94. PubMed ID: 2232249
[TBL] [Abstract][Full Text] [Related]
6. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
7. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
9. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
10. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of enzyme-linked immunosorbent assay for antinuclear antibodies].
Nakabayashi T; Kumagai T; Sakagami S; Furihata K; Katuyama T
Rinsho Byori; 1998 Sep; 46(9):942-7. PubMed ID: 9800481
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.
Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V
Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541
[TBL] [Abstract][Full Text] [Related]
15. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients.
Ruffatti A; Artifoni L; Glorioso S; Calligaro A; Doria A; Gambari P; Todesco S
J Rheumatol; 1985 Oct; 12(5):940-3. PubMed ID: 3878881
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of anticytoplasmic antibodies found on fluorescent antinuclear antibody testing.
Tesser JR; Rothberger H; Agudelo C
J Rheumatol; 1983 Apr; 10(2):227-34. PubMed ID: 6345769
[TBL] [Abstract][Full Text] [Related]
18. [Antinuclear antibody screening by an enzyme-linked immunosorbent assay using multiple nuclear antigens].
Iwata H; Aotsuka S; Okawa M; Kinoshita M; Sumiya M
Ryumachi; 1997 Aug; 37(4):548-55. PubMed ID: 9311280
[TBL] [Abstract][Full Text] [Related]
19. [Progress in clinical tests and the pathophysiological study of collagen diseases--anti-topoisomerase I antibodies and anticentromere antibodies].
Konndo H
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2409-13. PubMed ID: 9922659
[No Abstract] [Full Text] [Related]
20. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
Kallenberg CG; Pastoor GW; Wouda AA; The TH
Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
